2. Metabolic Enzyme/Protease
  3. HIF/HIF Prolyl-Hydroxylase
  4. HIF-2α-IN-18

HIF-2α-IN-18 is a selective HIF-2α inhibitor with a human IC50 of 8.1 nM. HIF-2α-IN-18 binds to the HIF-2α PAS-B domain, induces conformational perturbations at the HIF-2α/ARNT dimerization interface, destabilizes the HIF-2α/ARNT heterodimer, and blocks HIF-2α-mediated transcriptional activity. HIF-2α-IN-18 inhibits hypoxia-induced expression of HIF-2α target genes EPO and SERPINE1, without inhibiting HIF-1α target genes PGK1 and PDK1. HIF-2α-IN-18 can be used for the research of clear cell renal cell carcinoma, hepatocellular carcinoma[1].

For research use only. We do not sell to patients.

HIF-2α-IN-18

HIF-2α-IN-18 Chemical Structure

CAS No. : 2709068-47-1

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

HIF-2α-IN-18 Related Antibodies

Top Publications Citing Use of Products

View All HIF/HIF Prolyl-Hydroxylase Isoform Specific Products:

View All Isoforms
HIF-1α HIF PHD1

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

HIF-2α-IN-18 is a selective HIF-2α inhibitor with a human IC50 of 8.1 nM. HIF-2α-IN-18 binds to the HIF-2α PAS-B domain, induces conformational perturbations at the HIF-2α/ARNT dimerization interface, destabilizes the HIF-2α/ARNT heterodimer, and blocks HIF-2α-mediated transcriptional activity. HIF-2α-IN-18 inhibits hypoxia-induced expression of HIF-2α target genes EPO and SERPINE1, without inhibiting HIF-1α target genes PGK1 and PDK1. HIF-2α-IN-18 can be used for the research of clear cell renal cell carcinoma, hepatocellular carcinoma[1].

IC50 & Target[1]

HIF-2α

8.1 nM (IC50)

In Vitro

HIF-2α-IN-18 (Compound 13) (1 h; 45 min) potently inhibits binding to recombinant human HIF-2α PAS-B protein with an SPA IC50 of 14.8 nM[1].
HIF-2α-IN-18 (20 h) potently inhibits HIF-2α-mediated transcriptional activity in 786-O ccRCC cells with a cellular luciferase IC50 of 8.1 nM[1].
HIF-2α-IN-18 (20 h) inhibits HIF-2α-mediated transcriptional activity in 786-O ccRCC cells in 100% human serum with a cellular luciferase IC50 of 0.82 μM[1].
HIF-2α-IN-18 (0-50 μM; 20 h) inhibits HIF-2α-regulated VEGF-A secretion in 786-O ccRCC cells with an IC50 of 60 nM[1].
HIF-2α-IN-18 (0.01-10 μM; 20 h) potently and selectively inhibits hypoxia-induced HIF-2α target gene (EPO, SERPINE1) expression in Hep3B hepatocellular carcinoma cells without inhibiting HIF-1α target gene (PGK1, PDK1) expression[1].
HIF-2α-IN-18 (0.5 μM) has an in vitro intrinsic clearance of 29.2 μL/min/106 cells in human hepatocytes and 141 μL/min/106 cells in rat hepatocytes[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

HIF-2α-IN-18 Related Antibodies

Real Time qPCR[1]

Cell Line: Hep3B hepatocellular carcinoma cells (intact VHL, functional HIF-1α and HIF-2α)
Concentration: 0.01 μM; 0.1 μM; 10 μM
Incubation Time: 20 h
Result: Dose-dependently inhibited hypoxia-induced expression of HIF-2α target genes EPO and SERPINE1.
No robust or dose-dependent inhibition of HIF-1α target genes PGK1 and PDK1 was observed.
Maintained cell viability throughout the assay.
Parmacokinetics
Species Dose Route CL Vss T1/2 MRTINF_obs
Rat[1] 0.25 mg/kg i.v. 6.31 L/h/kg 9.60 L/kg 2.15 h 1.53 h
In Vivo

HIF-2α-IN-18 (Compound 13) (0.25 mg/kg; i.v.; single dose) exhibits an in vivo clearance of 6.31 L/h/kg, elimination half-life of 2.15 h, and 93.1% plasma protein binding in male Sprague-Dawley rats[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Sprague-Dawley (male, weight 200-250 g)[1]
Dosage: 0.25 mg/kg
Administration: i.v.; single dose
Result: Achieved an in vivo clearance (CL) of 6.31 L/h/kg.
Reached a volume of distribution at steady state (Vss) of 9.60 L/kg.
Had an elimination half-life (T1/2) of 2.15 h.
Exhibited a mean residence time (MRTINF) of 1.53 h.
Showed plasma protein binding (PPB) of 93.1% bound.
Molecular Weight

399.27

Formula

C18H8F7N3
CAS No.
SMILES

F[C@@H]1C(C=C(F)C=C2C#N)=C2N(C3=CC=C(C(F)(F)F)C(F)=C3C#N)C[C@@H]1F
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

HIF-2α-IN-18 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

HIF-2α-IN-182709068-47-1HIF/HIF Prolyl-HydroxylaseHypoxia-inducible factorsHIFsHIF-PHARNTclear cell renal cell carcinoma786-O ccRCC cellsHIF-2α PAS-B domainEPOHIF-1αVEGF-APGK1PDK1SERPINE1Inhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
HIF-2α-IN-18
Cat. No.:
HY-183583
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.